GE acquires stem cell supplier Biosafe
GE Health has acquired Biosafe in a move that it says will enable production of cell and gene therapies on an industrialized scale.
Archives for July 14, 2016
update
Juno trial restart positive, but CAR-T sector still on a learning curve says TxCell
The US FDA’s decision to let Juno Therapeutics restart its JCAR015 trial is positive, but the CAR-T sector must learn from safety and efficacy findings says French biotech TxCell.
Sartorius buys virus counting tech firm ViroCyt for $16m
Sartorius has bought virus quantification technology developer ViroCyt for $16m (€14m) in a deal that expands its analytics offering.